To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Criterion breakdown8 criteria · max 90
No grade to break down.Actions (4)
| Date | Time | Action |
|---|---|---|
| 2019-06-24 | — | Referred to the House Committee on Energy and Commerce. |
| 2019-06-24 | — | Introduced in House |
| 2019-06-24 | — | Introduced in House |
| 2019-07-24 | — | Sponsor introductory remarks on measure. (CR E971) |
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.